Literature DB >> 12379274

Sepsis: current concepts in intracellular signaling.

Derek Strassheim1, Jong Sung Park, Edward Abraham.   

Abstract

Sepsis is the systematic response to infection. In septic patients who develop severe disease, excessive inflammation damages the lungs, liver, kidneys, and cardiovascular system, leading to multiple organ failure and an associated high mortality rate. Sepsis is the leading cause of death in the intensive care unit. The damage to critical organs is primarily due to excessive acute inflammatory response rather than inadequate combat of the infection per se. Impairment of critical organs is closely associated with infiltration of activated neutrophils into those tissues as well as increased activation of endothelial, epithelial, and macrophage populations within the organs to produce a deregulated, overly aggressive inflammatory response. New pharmacological advances hold promise in improving survival from this multi-systemic disorder. Increasing understanding of the signal transduction pathways of inflammatory cells involved in the disease suggests that targeting specific kinases and transcriptional regulatory mechanisms may prove improve outcome from sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379274     DOI: 10.1016/s1357-2725(02)00049-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

1.  Heat stress prevents lipopolysaccharide-induced apoptosis in pulmonary microvascular endothelial cells by blocking calpain/p38 MAPK signalling.

Authors:  Zhi-Feng Liu; Dong Zheng; Guo-Chang Fan; Tianqing Peng; Lei Su
Journal:  Apoptosis       Date:  2016-08       Impact factor: 4.677

2.  The involvement of cholesterol in sepsis and tolerance to lipopolysaccharide highlighted by the transcriptome analysis of zebrafish (Danio rerio).

Authors:  Sonia Dios; Pablo Balseiro; Maria M Costa; Alejandro Romero; Sebastián Boltaña; Nerea Roher; Simon Mackenzie; Antonio Figueras; Beatriz Novoa
Journal:  Zebrafish       Date:  2014-09-02       Impact factor: 1.985

3.  Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage.

Authors:  Eray Kara; Ahmet Var; Seda Vatansever; Serap Cilaker; Yavuz Kaya; Teoman Coşkun
Journal:  Curr Ther Res Clin Exp       Date:  2004-05

4.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

5.  Opiates and the development of post-injury complications: a review.

Authors:  Martin G Schwacha
Journal:  Int J Clin Exp Med       Date:  2008-01-20

6.  Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury.

Authors:  Jaroslaw W Zmijewski; Emmanuel Lorne; Xia Zhao; Yuko Tsuruta; Yonggang Sha; Gang Liu; Gene P Siegal; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2008-04-24       Impact factor: 21.405

7.  Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-κB in Mice with Septic-Associated Lung Injury.

Authors:  Yuzhen Zhuo; Shukun Zhang; Caixia Li; Lei Yang; Hongwei Gao; Ximo Wang
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 8.  Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.

Authors:  William L Macias; David R Nelson; Mark Williams; Rekha Garg; Jonathan Janes; Andreas Sashegyi
Journal:  Crit Care       Date:  2005-09-22       Impact factor: 9.097

9.  Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin.

Authors:  Hamed Ghavimi; Sasan Sheidaei; Haleh Vaez; Elmira Zolali; Parina Asgharian; Hadi Hamishehkar
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

10.  Pharmacokinetics and ex vivo anti-inflammatory effects of oral misoprostol in horses.

Authors:  E M Martin; J M Schirmer; S L Jones; J L Davis
Journal:  Equine Vet J       Date:  2018-10-23       Impact factor: 2.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.